SSRI

schizophrenia mental health brain neurodegenerative

Biotech

J&J jettisons several programs, including ph. 2 Alzheimer's work

Johnson & Johnson is jettisoning several programs, with three of the culls taking place in the neuroscience field.

Gabrielle Masson Oct 15, 2024 2:00pm

magic mushroom

Vivocore combines InterVivo, Transpharmation to form CRO

Feb 10, 2022 2:18pm